Sunzen Group Berhad (KLSE:SUNZEN)

Market Cap	210.82M
Revenue (ttm)	77.29M
Net Income (ttm)	4.81M
Shares Out	766.61M
EPS (ttm)	0.01
PE Ratio	52.60
Forward PE	n/a
Dividend	0.00 (1.45%)
Ex-Dividend Date	Dec 12, 2025

Volume	1,819,400
Average Volume	495,745
Open	0.2700
Previous Close	0.2700
Day's Range	0.2700 - 0.2750
52-Week Range	0.2600 - 0.3500
Beta	0.46
RSI	53.66
Earnings Date	Nov 21, 2025

About Sunzen Group Berhad

Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services and licensed money lending activities; manufactures and sells tradition...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Employees: 168
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SUNZEN

Financial Performance

In 2025, Sunzen Group Berhad's revenue was 80.58 million, a decrease of -15.28% compared to the previous year's 95.12 million. Earnings were 2.59 million, a decrease of -57.10%.